Primary Site >> Liver Cancer
Gene >> EFNA5
| 1. | |||||||||||
| Journal: | Mol Cell Endocrinol. 2000 Apr 25;162(1-2):211-20. | ||||||||||
| Title: | Ligand structure-dependent differences in activation of estrogen receptor alpha in human HepG2 liver and U2 osteogenic cancer cell lines. | ||||||||||
| Author: | Yoon, K|Pellaroni, L|Ramamoorthy, K|Gaido, K|Safe, S | ||||||||||
| PMID: | 10854714 | ||||||||||
| 2. | |||||||||||
| Journal: | J Steroid Biochem Mol Biol. 2003 Jan;84(1):23-31. | ||||||||||
| Title: | 17 beta-estradiol- and 4-hydroxytamoxifen-induced transactivation in breast, endometrial and liver cancer cells is dependent on ER-subtype, cell and promoter context. | ||||||||||
| Author: | Castro-Rivera, Emely|Safe, Stephen | ||||||||||
| PMID: | 12648521 | ||||||||||
| 3. | |||||||||||
| Journal: | Oncotarget. 2015 Feb 28;6(6):4226-38. | ||||||||||
| Title: | Farnesoid X receptor associates with beta-catenin and inhibits its activity in hepatocellular carcinoma. | ||||||||||
| Author: | Liu, Xijun|Zhang, Xingwang|Ji, Lingling|Gu, Jianxin|Zhou, Meiling|Chen, She | ||||||||||
| PMID: | 25650661 | ||||||||||